Bydureon - Model 2mg - Bydureon - Powder and Solvent injection
From European Union - EU Products Using Alkermes Technologies
Bydureon 2mg powder and solvent for prolonged-release suspension for injection.
-
Most popular related searches
Product Details
Bydureon is indicated in adults 18 years and older with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose-lowering medicinal products including basal insulin, when the therapy in use, together with diet and exercise, does not provide adequate glycaemic control.For study results with respect to combinations, effects on glycaemic control and cardiovascular events, and the populations studied, see sections 4.4, 4.5, and 5.1.
Customer reviews
No reviews were found for Bydureon - Model 2mg - Bydureon - Powder and Solvent injection. Be the first to review!